Reversal of Intestinal Failure–Associated Liver Disease by Increasing Fish Oil in a Multi‐Oil Intravenous Lipid Emulsion in Adult Short Bowel–Syndrome Patients

摘要

Background Intestinal failure–associated liver disease (IFALD) is a serious complication of parenteral nutrition (PN). We report 2 cases of IFALD, which occurred in adult patients while on a regimen of multi‐oil intravenous lipid emulsion containing fish oil. Methods Patients initially received PN containing 1‐g/kg/d SMOFlipid 20% (SMOFlipid). When IFALD developed, lipid composition in PN was altered to include higher proportions of fish oil. Results Case 1 was a 23‐year‐old man with short‐bowel syndrome. He had been fully dependent on PN for approximately 11 months with a direct bilirubin level of 15.1 mg/dL. Doses of 0.15‐g/kg/d pure fish oil and 0.3–0.6‐g/kg/d SMOFlipid were administered for 56 days, and IFALD was resolved 59 days after adding fish oil. Case 2 was an 85‐year‐old man who received extensive small‐bowel resection because of internal herniation and small‐bowel necrosis. He had elevated direct bilirubin levels and was diagnosed with IFALD. Fish‐oil treatment was initiated after 50 days of receiving PN. The average daily amount of fish oil given was 0.14 g/kg/d. IFALD was resolved 44 days after adding Omegaven (Fresenius Kabi Austria Gmbh, Austria). Conclusion Two patients with advanced IFALD showed reversal of cholestasis by altering the lipid content of their PN to include more fish oil.